Trends in the prevalence of some transfusion-transmissible infections among blood donors in Port Harcourt, Nigeria

HAEMA

Volumn 8, Issue 2, 2005, Pages 273-277

  Ejele, Oseikhumen Adebayo ^a   Erhabor, Osaro ^a   Nwauche, Chijioke Adonye ^a  

^a UNIVERSITY OF PORT HARCOURT   (Nigeria)

Author keywords

Blood donors; HBV; HIV; Nigeria; Syphilis

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH PROGRAM; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; NIGERIA; RISK FACTOR; SCREENING TEST; SEROPREVALENCE; SYPHILIS; VIRUS DETECTION;

EID: 21744433069     PISSN: 11082682     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Klein HG. Allogeneic transfusion risk in the surgical patients. Am J Surg 1995; 170(6A suppl.): 21S-26S.
2. Clavel F, Cueutard D, Brun-Vezinet F et al. Isolation of a new human retrovirus from West African patients with AIDS. Science 1986; 233: 343-346.
3. Harry TO, Moses AE, Ola TO, Obi SO, Bejani MD. Increasing risk of transfusion associated AIDS as the pandemic spreads: experience in Maiduguri, Nigeria. J Trop Med Hyg 1993; 96: 313-133.
4. Baha MM, Hassan AW, Gashau W. Prevalence of Hepatitis B antigenaemia and Human Immunodeficiency virus in blood donors in Maiduguri, Nigeria. Niger J Med 2000; 9: 10-12.
5. Amadi AN, Mba LE. Distribution of HIV infection in Abia State, Nigeria. Niger J Med Invest Pract 2001; 2: 38-40.
6. Durosinmi MA, Ndububa DA, Alabi OA et al. Prevalence of HIV-1 and HBsAg in normal blood donors in Ile-Ife, Nigeria. Niger Med J 1992; 21: 138-140.
7. Glynn SA, Kleinman SH, Schreiber GB et al. Trends in incidence and prevalence of major transfusion transmissible viral infection in the United States. JAMA. 2000; 284: 229-235.
8. Carswell JW. HIV infection in healthy persons in Uganda. AIDS 1987; 1: 223-227.
9. Symuness WE, Harley EJ, Ikram H, Stevens CE. Socio-demographics of Hepatitis B. In Vyas GN, Cohen SN, Schmel R (eds): Viral hepatitis. Franklin Institute Press. Philadelphia, 1978, pp. 297-320.
10. Emmanuel J, Bassert M, Smith H et al. Measurement of ALT levels in Zimbabwean donor serum-a possible indicator of non A, non B hepatitis. Central African J Med 1989; 35: 469-470.
11. van der Sluis JJ, ten Kate FJ, Vuzevski VD, Kothe FC, Aelbers GM, van Eijk RV. Transfusion syphilis, survival of Treponema pallidium is stored blood. II. Dose dependence of experimentally determined survival times. Vox Sang 1985; 49: 390-399.
12. Federal Ministry of Health. Summary findings from the 2001 HIV/syphilis sentinel sero-prevalence survey in Nigeria. Information for policy makers, 2001, pp. 30-50.
13. Gibbs WW, Britten AFH. Guidelines for organization of blood transfusion services. Geneva. World Health Organization (WHO), 1992.
14. Schreiber GB, Busch M, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infection. N Engl J Med 1996; 334: 1685-1690
15. Erhabor O. The geometrically increasing prevalence of HIV infection and its attendant social implication in Port Harcourt, Nigeria. Niger Lab News J 2001; 4: 27-29.
16. Akinsete T, Akamu AS, Okany CC. Trends in HIV seropositivity among visa applicants in Lagos, Nigeria: A five year survey-1992 to 1996. Niger Post Grad Med J 1998; 5: 69-72.